Clinical trial
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women…
NCT00072462 · Queen Mary University of London, Other · Completed
Key facts
| NCT number | NCT00072462 |
|---|---|
| Title | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ |
| Official title | International Breast Cancer Intervention Study II (IBIS-II) (DCIS) |
| Acronym | IBIS-II DCIS |
| Lead sponsor | Queen Mary University of London, Other |
| Collaborators | Cancer Research UK |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | tamoxifen citrate, Anastrozole |
| Enrollment | 2,980 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2015 |
| Completion | May 31, 2021 |
| First posted | Nov 6, 2003 |
| Last update posted | Sep 19, 2024 |
| Countries | Australia, Austria, Belgium, Chile, France, Germany, Hungary, Ireland, Italy, Malta, Sweden, Switzerland and 2 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: